These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 8955873

  • 1. Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)tartaric acid.
    Marastoni M, Fantin G, Bortolotti F, Tomatis R.
    Arzneimittelforschung; 1996 Nov; 46(11):1099-101. PubMed ID: 8955873
    [Abstract] [Full Text] [Related]

  • 2. Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure.
    Marastoni M, Bergonzoni M, Bortolotti F, Tomatis R.
    Arzneimittelforschung; 1997 Jul; 47(7):889-92. PubMed ID: 9272250
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and human immunodeficiency virus (HIV)-1 protease inhibitory activity of tripeptide analogues containing a dioxoethylene moiety.
    Kitazaki T, Asano T, Kato K, Kishimoto S, Itoh K.
    Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2636-40. PubMed ID: 7697778
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Syntheses of HIV-protease inhibitors having a peptide moiety which binds to GP120.
    Asagarasu A, Uchiyama T, Achiwa K.
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):697-703. PubMed ID: 9579045
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HIV-1 protease inhibitors: ketomethylene isosteres with unusually high affinity compared with hydroxyethylene isostere analogs.
    Marinier A, Toth MV, Houseman K, Mueller R, Marshall GR.
    Bioorg Med Chem; 1994 Sep; 2(9):919-25. PubMed ID: 7712127
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Studies of human immunodeficiency virus type 1 (HIV-1) protease inhibitors. III. Structure-activity relationship of HIV-1 protease inhibitors containing cyclohexylalanylalanine hydroxyethylene dipeptide isostere.
    Sakurai M, Higashida S, Sugano M, Handa H, Komai T, Yagi R, Nishigaki T, Yabe Y.
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):534-40. PubMed ID: 8004698
    [Abstract] [Full Text] [Related]

  • 17. Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV.
    Nakatani S, Hidaka K, Ami E, Nakahara K, Sato A, Nguyen JT, Hamada Y, Hori Y, Ohnishi N, Nagai A, Kimura T, Hayashi Y, Kiso Y.
    J Med Chem; 2008 May 22; 51(10):2992-3004. PubMed ID: 18426195
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis of novel inhibitors of the HIV-1 protease: difunctional enols of simple N-protected amino acids.
    Vaillancourt M, Vanasse B, Le Berre N, Cohen E, Sauvé G.
    Bioorg Med Chem; 1994 May 22; 2(5):343-55. PubMed ID: 7922146
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors.
    Marastoni M, Bazzaro M, Bortolotti F, Tomatis R.
    Bioorg Med Chem; 2003 May 29; 11(11):2477-83. PubMed ID: 12735995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.